Good morning :)
Switch to
Place Order

Solara Active Pharma Sciences Ltd

SOLARA
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,592 cr, stock is ranked 887
High RiskStock is 3.37x as volatile as Nifty
435.901.45% (-6.40)
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹1,592 cr, stock is ranked 887
High RiskStock is 3.37x as volatile as Nifty

Key Metrics

PE RatioPE RatioPB RatioPB RatioDividend YieldDiv. Yield
-27.381.04
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
35.354.320.90%

Forecast & RatingsDetailed Forecast 

75%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

SSL Pharma Sciences is a manufacturer of pharmaceutical preparation

Investor PresentationView older 

May 2, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Financial TrendFinancial statements 

2019202020212022+1.40+1.35+1.65+1.29+0.06+0.11+0.22-0.06
Revenue
Profit
Loss
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnNov 21, 2022

Solara Active Pharma Sciences Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Solara Active Pharma Sciences Limited has informed the Exchange about related party transaction for the period ended September 2022 | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnNov 15, 2022

Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Solara Active Pharma Sciences Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Cash Dividend 
Ex. DateAug 18, 2021

Final • Div/Share: ₹ 3

See all events